LA JOLLA INSTITUTE FOR IMMUNOLOGY

Study reveals blocking immune system 'messenger' might treat severe asthma

The Journal of Allergy and Clinical Immunology, suggest people with both types of asthma may benefit from therapies that block interactions between a molecule called histamine-releasing factor (HRF) and antibodies called immunoglobulin E .